Work

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

Year: 2013

Type: article

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(13)70424-8

Authors: Ethan Basch, Karen Autio, Charles J Ryan, Peter Mulders, Neal Shore, Thian Kheoh, Karim Fizazi, Christopher J Logothetis, Dana Rathkopf, Matthew R Smith, Paul N Mainwaring, Yanni Hao, Thomas Griffin, Susan Li, Michael L Meyers, Arturo Molina, Charles Cleeland

Institutions: University of North Carolina at Chapel Hill, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Radboud University Nijmegen, Radboud University Medical Center, Carolina Urologic Research Center, Janssen Research & Development (United States), Université Paris-Sud, Institut Gustave Roussy, The University of Texas MD Anderson Cancer Center, Harvard University, Massachusetts General Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2127307826

FWCI: 13.11

Cites: 32

Cited by: 153

Related to: 10